Investors
5 investorsAll
Early stage
Mid stage
Late stage
Mid stage· 5
Sean Doherty
Senior Fellow, Harvard Advanced Leadership Initiative
Board Member
mid stage
3 investments
Aug 2019
Sean Doherty
Senior Fellow, Harvard Advanced Leadership Initiative
Board Member
mid stage
3 investments
Aug 2019
Jason Dinges
Venture Capital at Morningside Technology Advisory LLC
Board Member
mid stage
25 investments
Jul 2019
Jason Dinges
Venture Capital at Morningside Technology Advisory LLC
Board Member
mid stage
25 investments
Jul 2019
Nandan Padukone
Innovation Leader, Biotech C-suite Executive, Board Member
CEO, Board Member
mid stage
3 investments
2019
Investor geography1 country
Frequently asked questions
Who invested in IM Therapeutics?
IM Therapeutics has 5 investors on record on gritt.io, 5 mid-stage.
When did IM Therapeutics last raise funding?
The most recent investment in IM Therapeutics recorded on gritt.io was in August 2019.
When was IM Therapeutics founded?
IM Therapeutics was founded in 2015.
What industry is IM Therapeutics in?
IM Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is IM Therapeutics based?
IM Therapeutics is headquartered in Woburn, United States.